These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30039732)

  • 1. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
    Badalamente MA; Hurst LC; Benhaim P; Cohen BM
    J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
    Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
    J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
    Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
    J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
    Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
    J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
    J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
    Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
    Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
    Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
    J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
    Skov ST; Bisgaard T; Søndergaard P; Lange J
    J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
    Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB
    J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
    Nayar SK; Pfisterer D; Ingari JV
    Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
    Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
    Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures.
    Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC
    J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
    Hwee YK; Park D; Vinas M; Litts C; Friedman D
    Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
    McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B
    Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase Tenotomy for Dupuytren Boutonniere.
    Denkler KA; Vaughn CJ; Park KM; Hansen SL
    Plast Reconstr Surg; 2021 Nov; 148(5):764e-768e. PubMed ID: 34705780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.
    Nordenskjöld J; Lauritzson A; Åkesson A; Atroshi I
    Acta Orthop; 2019 Dec; 90(6):517-522. PubMed ID: 31500473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
    Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
    Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.